Formerly known as Linguagen Corporation, Redpoint Bio Corporation, is a wholly owned subsidiary of Robcor, applying biotechnology and modern pharmaceutical techniques to provide solutions to problems related to gustation and olfaction. The firm is development stage biotechnology company focused on the development of healthier foods and new approaches for the treatment of diabetes and obesity by understanding the biology of taste and its relationship to metabolism, satiety, and diabetes. Redpoint had entered into a license and commercialization agreement with International Flavors and Fragrances Inc. for the development, manufacture, use, and commercialization of RP44, which is a component of the stevia plant that works as a sweetness enhancer amplifying the existing sugary sweetness in a food or beverage. Focused on preserving the value of that License and Commercialization Agreement, the Company continues its efforts to reduce its liabilities and sell its remaining assets. Given its lack of resources, the Company is not currently performing any research and development activities.
